Cyclerion Therapeutics Income Statement (2019-2025) | CYCN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025
Revenue & cost
Revenue (Quarter)	0.13M	0.06M	3.00M	0.35M	0.53M	0.71M	0.31M									0.19M	1.81M	0.08M	0.09M	0.88M
Operating items
Research & Development (Quarter)	12.09M	8.09M	12.05M	7.03M	10.46M	9.74M	10.22M	1.41M	1.18M	0.57M	0.34M	0.58M	0.02M	0.04M	0.10M	0.08M	0.06M	0.04M	0.06M	0.35M
Selling, General & Administrative (Quarter)	7.26M	5.37M	6.24M	4.60M	4.41M	3.95M	3.52M	3.10M	3.28M	2.70M	1.53M	2.13M	1.77M	1.57M	1.28M	1.24M	1.25M	1.50M	1.71M	1.53M
Other Operating Expenses (Quarter)			-0.88M									3.30M							1.30M
Operating Expenses (Quarter)	19.36M	13.46M	19.18M	11.63M	14.87M	13.70M	13.74M	4.52M	4.46M	3.27M	1.86M	6.01M	1.79M	1.62M	1.38M	1.32M	1.30M	1.54M	1.76M	1.88M
Operating Income (Quarter)	-19.22M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-4.52M	-4.46M	-3.27M	-1.86M	-6.01M	-1.79M	-1.62M	-1.38M	-1.13M	0.50M	-1.46M	-1.67M	-1.01M
EBIT (Quarter)	-19.22M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-4.52M	-4.46M	-3.27M	-1.86M	-6.01M	-1.79M	-1.62M	-1.38M	-1.13M	0.50M	-1.46M	-1.67M	-1.01M
Non-operating items
Interest & Investment Income (Quarter)	-0.00M
Other Non Operating Income (Quarter)												0.11M	0.10M	0.08M	0.06M	0.04M	0.03M	0.03M	0.03M	0.03M
Non Operating Income (Quarter)	-0.00M	-0.00M	-0.01M	-0.01M	-0.00M	0.01M	0.04M	0.11M	0.13M	0.09M	0.06M	0.11M	0.10M	0.08M	0.06M	0.41M	0.03M	0.03M	1.35M	0.03M
Net income details
EBT (Quarter)	-19.23M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-4.52M	-4.46M	-3.27M	-1.86M	-6.01M	-1.79M	-1.62M	-1.38M	-1.13M	0.50M	-1.46M	-1.67M	-1.01M
Profit After Tax (Quarter)	-19.23M	-6.95M	-16.18M	-11.29M	-10.78M	-12.98M	-13.39M	-10.50M	44.10M	-6.95M	-4.18M	-5.91M	-1.79M	-1.54M	-1.32M	-0.72M	0.53M	-1.43M	-0.32M	-0.98M
Income from Continuing Operations (Quarter)	-19.23M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-4.52M	-4.46M	-3.27M	-1.86M	-6.01M	-1.79M	-1.62M	-1.38M	-1.13M	0.50M	-1.46M	-1.67M	-1.01M
Consolidated Net Income (Quarter)	-19.23M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-6.09M	-2.89M	-3.77M	-2.38M	13.47M						-1.46M	-1.67M	-1.01M
Income towards Parent Company (Quarter)	-19.23M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-6.09M	-2.89M	-3.77M	-2.38M	13.47M						-1.46M	-1.67M	-1.01M
Net Income towards Common Stockholders (Quarter)	-19.23M	-13.39M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-6.09M	-2.89M	-3.77M	-2.38M	13.47M						-1.46M	-1.67M	-1.01M
Additional items
EPS (Basic) (Quarter)	-0.55	-0.39	-0.45	-0.26	-0.24	-0.30	-6.16	-0.24	-0.16	-0.16	-1.83	5.53						-0.57	-0.59	-0.34
EPS (Weighted Average and Diluted) (Quarter)			-0.45	-0.26	-0.24	-0.30	-6.16	-0.24	-0.16	-0.16	-1.83	5.86						-0.57	-0.59	-0.31
Shares Outstanding (Weighted Average) (Quarter)	30.40M	34.08M	35.71M	43.29M	39.14M	0.04M	2.17M	2.17M	2.17M	2.18M	2.23M	2.44M	2.34M	2.49M	2.51M	2.51M	2.52M	2.56M	2.84M	2.97M
Shares Outstanding (Diluted Average) (Quarter)			34.90M	43.29M	39.14M	0.04M	2.17M	2.17M	2.17M	2.18M	2.28M	2.30M	2.34M	2.49M	2.50M	2.53M	2.52M	2.56M	2.84M	3.23M
EBITDA (Quarter)	-19.23M	-13.40M	-16.18M	-11.29M	-14.34M	-12.98M	-13.43M	-10.50M	-4.46M	-6.95M	-4.18M	-6.01M	-1.79M	-1.55M	-1.32M	-0.72M	0.50M	-1.46M	-1.67M	-0.98M

Research Tools

Cyclerion Therapeutics Income Statement (2019-2025) | CYCN

Create an account

Sign In

Reset Password